S
Singular Genomics Systems Inc
NASDAQ:OMIC
Singular Genomics Systems Inc
NASDAQ:OMIC
Price:
0.371 USD
-2.37%
Market Closed
Updated:
May 17, 2024
Balance Sheet
Balance Sheet Decomposition
Singular Genomics Systems Inc
Singular Genomics Systems Inc
| Current Assets | 192.2m |
| Cash & Short-Term Investments | 175.4m |
| Receivables | 565k |
| Other Current Assets | 16.3m |
| Non-Current Assets | 73.2m |
| PP&E | 71.5m |
| Other Non-Current Assets | 1.8m |
| Current Liabilities | 18.3m |
| Accounts Payable | 2.6m |
| Accrued Liabilities | 13.8m |
| Other Current Liabilities | 1.9m |
| Non-Current Liabilities | 68.2m |
| Long-Term Debt | 8.9m |
| Other Non-Current Liabilities | 59.3m |
Balance Sheet
Singular Genomics Systems Inc
Singular Genomics Systems Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
6
|
12
|
201
|
74
|
16
|
|
| Cash Equivalents |
6
|
12
|
201
|
74
|
16
|
|
| Short-Term Investments |
41
|
15
|
139
|
171
|
159
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
3
|
18
|
14
|
|
| Other Current Assets |
0
|
1
|
5
|
4
|
3
|
|
| Total Current Assets |
47
|
28
|
348
|
268
|
192
|
|
| PP&E Net |
2
|
2
|
6
|
57
|
71
|
|
| PP&E Gross |
2
|
2
|
6
|
57
|
71
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
5
|
8
|
|
| Other Long-Term Assets |
0
|
1
|
2
|
3
|
2
|
|
| Total Assets |
48
N/A
|
31
-37%
|
356
+1 066%
|
328
-8%
|
265
-19%
|
|
| Liabilities | ||||||
| Accounts Payable |
1
|
0
|
2
|
3
|
3
|
|
| Accrued Liabilities |
1
|
2
|
4
|
11
|
14
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
2
|
|
| Total Current Liabilities |
1
|
4
|
7
|
14
|
18
|
|
| Long-Term Debt |
2
|
9
|
10
|
10
|
9
|
|
| Other Liabilities |
0
|
1
|
3
|
44
|
59
|
|
| Total Liabilities |
4
N/A
|
13
+249%
|
20
+51%
|
68
+247%
|
86
+28%
|
|
| Equity | ||||||
| Common Stock |
69
|
69
|
0
|
0
|
0
|
|
| Retained Earnings |
25
|
53
|
152
|
243
|
338
|
|
| Additional Paid In Capital |
0
|
2
|
488
|
504
|
516
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
45
N/A
|
18
-60%
|
336
+1 810%
|
260
-23%
|
179
-31%
|
|
| Total Liabilities & Equity |
48
N/A
|
31
-37%
|
356
+1 066%
|
328
-8%
|
265
-19%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
69
|
69
|
72
|
72
|
74
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
